Home›Companies›Biotech & Pharma›HOPE-Neuron

HOPE-Neuron Therapeutx, Inc.

Develops a non-drug treatment for people with ALS and other neurodegenerative diseases.

Updated Nov 10, 2026·Latest SEC filing Jul 2, 2026·Suggest an edit

About HOPE-Neuron

HOPE-Neuron is a private company based in Phoenix, Arizona, incorporated in 2025 in Delaware. It has reported $150,000 raised in one offering on Form D since July 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 12, 2026Jul 2, 2026$150,000fully sold1$150KDebt, Convertible Promissory Note, including underlying Capital Stock upon conversion and upon satisfaction of certain events.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on HOPE-Neuron's Form D filed Jul 2, 2026.

Ronald Lane
Ronald Lane
Founder & Executive Chairman
John Louf
John Louf
Chief Technology Officer
Karina Fedasz
Karina Fedasz
Interim CFO
Mark Forney
Mark Forney
Vice President Business Development

Sources

  1. SECHOPE-Neuron Therapeutx, Inc. filing history
  2. CompanyHOPE-Neuron team